Self Management & Reminders With Technology: SMART Appraisal of an

Status Completed

Clinical Trial Summary

This project seeks to improve health care outcomes in complex patients with cardiovascular disease (CVD) or who are at high risk for developing CVD by promoting patient self-management. This will be accomplished in 4 diverse, large primary care practices through the following 3 aims: (1) develop a patient-specific, active component to an existing electronic PHR directed towards patients with complex illnesses that is designed to reduce the risk of cardiovascular disease, (2) conduct a randomized controlled trial of the effectiveness of passive and active PHRs for improving adherence and clinical outcomes of complex patients in an ambulatory environment, and (3) enumerate the barriers and facilitators to implementation and use of an PHR among providers and patients in an ambulatory setting. To accomplish the aim 1, a users group will be assembled to determine which potential features of an 'active PHR' would be most acceptable and useful to them. To accomplish the 2nd aim, 1,000 patients with complex chronic disease leading to increased cardiovascular risk (i.e., CVD or 2 of the 4 conditions of hypertension (HTN), diabetes mellitus (DM), or hyperlipidemia requiring at least one medication for control) will be randomized to a passive PHR (n=500), or an active PHR (n=500) at 4 sites where the PHR currently is installed and in use. Outcomes to be assessed include improvement in control of risk factors (e.g., blood pressure), frequency of compliance with testing guidelines (e.g., annual dilated retinal exams in DM), and clinical outcomes (e.g., myocardial infarction, hospitalizations). Aim 3 will be accomplished by surveying all participants using the PHR, along with nurses and physicians at the study sites, and by conducting focus groups of PHR participants, nurses, and physicians to determine the most useful features of the PHR and to barriers and facilitators of use.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Health Services Research

Related Conditions & MeSH terms

Cardiovascular Risk

Clinical Trial Details

NCT number	NCT01078532
Study type	Interventional
Source	University of Pittsburgh
Contact
Status	Completed
Phase	N/A
Start date	April 2010
Completion date	September 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01139827` - Association Between Framingham Risk Score, hsCRP and Vascular Inflammation: Analysis With 18F-Fluorodeoxyglucose Positron Emission Tomography	N/A
Recruiting	`NCT05767073` - LIVES: Personalized Lifestyle Intervention for Patients With Depression	N/A
Completed	`NCT04626505` - Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan.	Phase 2
Completed	`NCT00856882` - The Effects of Soy Protein and Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk Factors	N/A
Completed	`NCT04330937` - Clinical Trial on the Effectiveness of Citrolive	N/A
Completed	`NCT01781416` - Level of Concordance Between Patients Perception and Physicians Evaluation of Cardiovascular Risk	N/A
Completed	`NCT01475513` - Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women	Phase 4
Enrolling by invitation	`NCT06122961` - Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)
Completed	`NCT04506749` - To Evaluate the Efficacy of a Nutraceutical in Reducing Cardiovascular Risk in Healthy Subjects	N/A
Completed	`NCT03412175` - CREATION Health Lifestyle Intervention	N/A
Completed	`NCT02144922` - Effect of Pitavastatin on Coronary Flow Reserve in Hypertensive Patients	Phase 4
Completed	`NCT00921752` - C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using Effective Statins (CORVUS)	N/A
Completed	`NCT00697580` - Strength and Nutrition Outcomes for Latino Adolescents	N/A
Enrolling by invitation	`NCT04450914` - Implementing Shared Decision Making (SDM) For Individualized CV Prevention (SDM4IP)	N/A
Completed	`NCT01003574` - Evaluation of Cardiovascular Health Outcomes Among Survivors	N/A
Not yet recruiting	`NCT06118281` - ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack	Phase 3
Completed	`NCT01441323` - Strength Training and Nutrition Development for African American Youth	N/A
Completed	`NCT01103648` - Effect of Simvastatin and Ezetimibe on Lipid and Inflammation	N/A
Completed	`NCT01015092` - Cardiovascular Risk Evaluation and Antiretrovirals in HIV	N/A
Not yet recruiting	`NCT05882266` - The Role of Plant-Based Omega-3 Fatty Acids and Molecular Characterisation in Individuals With Cardiovascular(CVD) Risk	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Self Management and Reminders With Technology: SMART Appraisal of an Integrated Personal Health Record (PHR) — SMART PHR

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms